Ian S Zenlea1, Carly E Milliren2, Lauren Mednick3, Erinn T Rhodes4. 1. Division of Endocrinology, Boston Children's Hospital, Boston, Mass. Electronic address: Ian.Zenlea@childrens.harvard.edu. 2. Clinical Research Center, Boston Children's Hospital, Boston, Mass. 3. Department of Psychology, Boston Children's Hospital, Boston, Mass. 4. Division of Endocrinology, Boston Children's Hospital, Boston, Mass; Department of Pediatrics, Harvard Medical School, Boston, Mass.
Abstract
OBJECTIVE: To determine the frequency of depression screening during ambulatory, office-based visits for adolescents seen in general/family medicine or pediatric practices in the United States using nationally representative data; to determine the patient-, provider-, and visit-level factors associated with depression screening during ambulatory visits to inform recommendations to promote screening. METHODS: This cross-sectional study used the 2005-2010 National Ambulatory Medical Care and National Hospital Ambulatory Medical Care Surveys. Data were limited to ambulatory, office-based visits to general/family medicine or pediatrics clinics for adolescents aged 12 to 18 years who did not have a documented diagnosis of depression. RESULTS: Depression screening was rare (0.2%; 95% confidence interval [CI] 0.1-0.3), and it was 80% less likely to occur during visits for Hispanic compared to non-Hispanic white adolescents (adjusted odds ratio [aOR] 0.2, 95% CI 0.1-0.7). Depression screening was 9.1 times more likely in the Northeast compared to the West (aOR 9.1, 95% CI 2.2-38.1) if there were no visits within past 12 months compared to 6 or more visits (aOR 6.1; 95% CI 1.8-20.4), and if stress management (aOR 24.2, 95% CI 11.8-49.5) or other mental health counseling (aOR 5.2, 95% CI 1.2-23.6) were provided. CONCLUSIONS: Depression screening for adolescents is rare and is associated with racial/ethnic and regional disparities. The integration of behavioral and mental health services within the patient-centered medical home might assist providers in identifying and treating depression and in addressing such disparities.
OBJECTIVE: To determine the frequency of depression screening during ambulatory, office-based visits for adolescents seen in general/family medicine or pediatric practices in the United States using nationally representative data; to determine the patient-, provider-, and visit-level factors associated with depression screening during ambulatory visits to inform recommendations to promote screening. METHODS: This cross-sectional study used the 2005-2010 National Ambulatory Medical Care and National Hospital Ambulatory Medical Care Surveys. Data were limited to ambulatory, office-based visits to general/family medicine or pediatrics clinics for adolescents aged 12 to 18 years who did not have a documented diagnosis of depression. RESULTS:Depression screening was rare (0.2%; 95% confidence interval [CI] 0.1-0.3), and it was 80% less likely to occur during visits for Hispanic compared to non-Hispanic white adolescents (adjusted odds ratio [aOR] 0.2, 95% CI 0.1-0.7). Depression screening was 9.1 times more likely in the Northeast compared to the West (aOR 9.1, 95% CI 2.2-38.1) if there were no visits within past 12 months compared to 6 or more visits (aOR 6.1; 95% CI 1.8-20.4), and if stress management (aOR 24.2, 95% CI 11.8-49.5) or other mental health counseling (aOR 5.2, 95% CI 1.2-23.6) were provided. CONCLUSIONS:Depression screening for adolescents is rare and is associated with racial/ethnic and regional disparities. The integration of behavioral and mental health services within the patient-centered medical home might assist providers in identifying and treating depression and in addressing such disparities.
Authors: Bonnie B Strickland; Jessica R Jones; Reem M Ghandour; Michael D Kogan; Paul W Newacheck Journal: Pediatrics Date: 2011-03-14 Impact factor: 7.124
Authors: Anna B Flynn; Kate E Fothergill; Holly C Wilcox; Elizabeth Coleclough; Russell Horwitz; Anne Ruble; Matthew D Burkey; Lawrence S Wissow Journal: Acad Pediatr Date: 2015 Sep-Oct Impact factor: 3.107
Authors: Anne M Gadomski; Kate E Fothergill; Susan Larson; Lawrence S Wissow; Heather Winegrad; Zsolt J Nagykaldi; Ardis L Olson; Debra L Roter Journal: J Adolesc Health Date: 2015-01-10 Impact factor: 5.012
Authors: R Eric Lewandowski; Briannon O'Connor; Andrew Bertagnolli; Arne Beck; Aldo Tinoco; William P Gardner; Christine X Jelinek-Berents; Douglas A Newton; Kris F Wain; Jennifer M Boggs; Nancy E Brace; Patricia deSa; Sarah Hudson Scholle; Kimberly Hoagwood; Sarah McCue Horwitz Journal: Psychiatr Serv Date: 2016-02-14 Impact factor: 3.084
Authors: Steven D Langerman; Gia M Badolato; Alexandra Rucker; Lenore Jarvis; Shilpa J Patel; Monika K Goyal Journal: J Adolesc Health Date: 2019-07-31 Impact factor: 5.012
Authors: Aiswarya Laks Nandakumar; Jennifer L Vande Voort; Paul A Nakonezny; Scott S Orth; Magdalena Romanowicz; Ayse Irem Sonmez; Jessica A Ward; Sandra J Rackley; John E Huxsahl; Paul E Croarkin Journal: J Child Adolesc Psychopharmacol Date: 2018-11-02 Impact factor: 2.576
Authors: Molly Davis; Katelin Hoskins; Mary Phan; Carlin Hoffacker; Megan Reilly; Perrin B Fugo; Jami F Young; Rinad S Beidas Journal: J Adolesc Health Date: 2021-12-23 Impact factor: 7.830